The FDA has granted Novo Nordisk approval for a pair of its insulin injection pens -- the NovoLog FlexTouch and the Levemir FLexTouch. The devices, slated for U.S. release next year, are each prefilled with 300 units of insulin and work with the company's NovoFine and NovoTwist needles. The pens were approved in Europe two years ago.

Full Story:

Related Summaries